CTNNB1 and colorectal cancer: Tankyrase inhibitors are a class of small molecule inhibitors that lower the elevated beta-catenin levels implicated in the proliferative pathobiology of colorectal cancer (Mizutani et al., 2018; Zhang and Lum, 2018) and appear to induce condensates.